Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.
暂无分享,去创建一个
L. Gordon | J. Murray | N. Bartlett | T. Witzig | G. Wiseman | R. Schilder | P. Multani | C. White | M. Saleh | A. Grillo‐López | S. Spies | R. Allen | M. Saleh